Skip to content
Clinical Trials – home
CyprusBack to Cyprus

Clinical trials in Agios Dometios

14 clinical trials in Agios Dometios, Cyprus. Every trial is listed in the EU Clinical Trials Register and updated daily.

Agios Dometios at a glance
14
clinical trials
  • Paediatric trials0
  • Research sites0
Type of trial
Recruitment status
Quick filters

14 trials in Agios Dometios

Open in trial search

Back pain

Recruiting

Efficacy and tolerability of diclofenac potassium + thiocolchicoside versus diclofenac potassium in patients with acute severe low back pain

Registered drug
Countries:CyprusCyprus
  • Participants:18–64 years · 65+ years
  • Substances:Diclofenac potassium
  • Sponsor:Verisfield Single Member S.A.

Long-Term Safety and Efficacy Study of Eplontersen in Patients with Hereditary Transthyretin-Mediated Amyloid Polyneuropathy

InvestigationalNo placebo
Countries:CyprusCyprus
  • Participants:18–64 years · 65+ years
  • Substances:Eplontersen
  • Sponsor:Ionis Pharmaceuticals Inc.

Study on Elacestrant for Treating ER+/HER2- Breast Cancer in Patients with ctDNA Relapse

Registered drugNo placebo
Countries:CyprusCyprus
  • Participants:18–64 years · 65+ years
  • Substances:Anastrozole
  • Sponsor:European Organisation For Research And Treatment Of Cancer

Leiomyosarcoma+1

Recruiting

Study on the Effect of Chemotherapy with Ifosfamide, Dacarbazine, and Epirubicin Hydrochloride Before Surgery for Patients with High-Risk Retroperitoneal Sarcoma

Registered drugNo placebo
Countries:CyprusCyprus
  • Participants:18–64 years · 65+ years
  • Substances:Dacarbazine
  • Sponsor:European Organisation For Research And Treatment Of Cancer

Drug use disorder

Not yet recruiting

Study on Ketamine to Prevent Relapse in Patients with Opioid Use Disorder

Registered drugNo placebo
Countries:CyprusCyprus
  • Participants:18–64 years · 65+ years
  • Substances:Ketamine
  • Sponsor:University of Cyprus

Study on Improving Quality of Life for Early Breast Cancer Patients Using Duloxetine and Furosemide to Manage Endocrine Therapy-Related Pain

Registered drugNo placebo
Countries:CyprusCyprus
  • Participants:18–64 years · 65+ years
  • Substances:Duloxetine
  • Sponsor:European Organisation For Research And Treatment Of Cancer

Study on Long-term Safety and Efficacy of Efgartigimod in Adults with Active Idiopathic Inflammatory Myopathy Using a Drug Combination

Registered drugNo placebo
Countries:CyprusCyprus
  • Participants:18–64 years · 65+ years
  • Substances:Azathioprine
  • Sponsor:Argenx

Polyneuropathy

Not recruiting

A study to evaluate the safety and effectiveness of nucresiran and vutrisiran in patients with hereditary transthyretin amyloidosis with polyneuropathy

Registered drugNo placebo
Countries:CyprusCyprus
  • Participants:18–64 years · 65+ years
  • Substances:Nucresiran
  • Sponsor:Alnylam Pharmaceuticals Inc.

Ocular myasthenia

Not recruiting

Study on the Effectiveness and Safety of Efgartigimod in Adults with Ocular Myasthenia Gravis

Registered drug
Countries:CyprusCyprus
  • Participants:18–64 years · 65+ years
  • Substances:Efgartigimod Alfa
  • Sponsor:Argenx

Study on the Effects and Safety of Efgartigimod PH20 SC for Adults with Active Idiopathic Inflammatory Myopathy

Investigational
Countries:CyprusCyprus
  • Participants:18–64 years · 65+ years
  • Substances:Efgartigimod Alfa
  • Sponsor:Argenx

Myasthenia gravis

Not recruiting

Study on Efgartigimod IV for Adults with Seronegative Generalized Myasthenia Gravis

Registered drug
Countries:CyprusCyprus
  • Participants:18–64 years · 65+ years
  • Substances:Efgartigimod Alfa
  • Sponsor:Argenx

Neoplasm

Not recruiting

Study on the Safety of Tiragolumab and Atezolizumab for Patients with Advanced or Metastatic Solid Tumors

InvestigationalNo placebo
Countries:CyprusCyprus
  • Participants:18–64 years · 65+ years
  • Sponsor:F. Hoffmann-La Roche AG

Other cities in Cyprus

The busiest research cities in the country

All 4 cities in Cyprus

Clinical research in Agios Dometios

What the registry says about research in the country

01 Myasthenia Research

Innovative clinical studies focusing on Ocular Myasthenia Gravis and Generalized Myasthenia Gravis, evaluating new therapeutic approaches using efgartigimod in different formulations. These trials aim to improve treatment options for patients with varying presentations of the condition.

  • Ocular Myasthenia Gravis Treatment
  • Seronegative MG Therapies
  • Subcutaneous Treatment Development

Research emphasizes both efficacy and safety profiles in different patient populations.

02 Inflammatory Myopathy Studies

Comprehensive research into Idiopathic Inflammatory Myopathy, investigating both short-term and long-term treatment outcomes. These trials evaluate novel therapeutic approaches while maintaining established immunomodulatory therapies.

  • Long-term Safety Assessment
  • Treatment Efficacy Evaluation
  • Combined Therapy Approaches

Studies focus on developing sustainable treatment options for chronic inflammatory conditions.

03 Amyloidosis Research

Groundbreaking studies on Hereditary Transthyretin Amyloidosis, including investigations of new compounds targeting neurologic impairment. The research encompasses both established and innovative therapeutic approaches.

  • Polyneuropathy Treatment
  • Novel Therapeutic Compounds
  • Extended Treatment Protocols

These trials aim to advance treatment options for patients with hereditary amyloid disorders.

Clinical Trials Concierge

Prefer not to search on your own, or looking for clinical trials for a rare disease?

Tell us about your condition – we search every trial in Europe and connect you with the right site.